

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 4.65994077 |
| 2 | locomotory exploration behavior (GO:0035641) | 4.50901649 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.47665059 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.44183681 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.14272367 |
| 6 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.03832335 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.00792454 |
| 8 | glutamate secretion (GO:0014047) | 3.98531932 |
| 9 | vocalization behavior (GO:0071625) | 3.79601679 |
| 10 | sodium ion export (GO:0071436) | 3.77383155 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 3.68831896 |
| 12 | cell communication by electrical coupling (GO:0010644) | 3.62754148 |
| 13 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.56489869 |
| 14 | layer formation in cerebral cortex (GO:0021819) | 3.54357388 |
| 15 | cellular potassium ion homeostasis (GO:0030007) | 3.43629016 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.40317848 |
| 17 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.37240623 |
| 18 | plasma membrane repair (GO:0001778) | 3.31225221 |
| 19 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.26837985 |
| 20 | activation of protein kinase A activity (GO:0034199) | 3.26462483 |
| 21 | regulation of synapse structural plasticity (GO:0051823) | 3.20018407 |
| 22 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.17029303 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 3.12975716 |
| 24 | cell communication involved in cardiac conduction (GO:0086065) | 3.10505956 |
| 25 | regulation of ARF protein signal transduction (GO:0032012) | 3.08276811 |
| 26 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.06309438 |
| 27 | inositol phosphate catabolic process (GO:0071545) | 3.05759035 |
| 28 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.05758545 |
| 29 | neurotransmitter secretion (GO:0007269) | 3.04561568 |
| 30 | cardiac myofibril assembly (GO:0055003) | 3.03914112 |
| 31 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.99914199 |
| 32 | potassium ion import (GO:0010107) | 2.99038036 |
| 33 | exploration behavior (GO:0035640) | 2.95030566 |
| 34 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.94789870 |
| 35 | proline transport (GO:0015824) | 2.92968755 |
| 36 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.92483499 |
| 37 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.91090644 |
| 38 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.89129604 |
| 39 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.86447821 |
| 40 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.85216223 |
| 41 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.83227394 |
| 42 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.82633017 |
| 43 | protein localization to synapse (GO:0035418) | 2.82600344 |
| 44 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.82133320 |
| 45 | regulation of membrane repolarization (GO:0060306) | 2.81623166 |
| 46 | adaptation of signaling pathway (GO:0023058) | 2.81457148 |
| 47 | dendritic spine morphogenesis (GO:0060997) | 2.81270623 |
| 48 | presynaptic membrane assembly (GO:0097105) | 2.78708073 |
| 49 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.77506826 |
| 50 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.77314907 |
| 51 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.76223266 |
| 52 | negative regulation of protein oligomerization (GO:0032460) | 2.75218545 |
| 53 | macroautophagy (GO:0016236) | 2.75058916 |
| 54 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.70972743 |
| 55 | positive regulation of glycolytic process (GO:0045821) | 2.70216450 |
| 56 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.69051757 |
| 57 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.68929779 |
| 58 | neuromuscular process controlling balance (GO:0050885) | 2.68258515 |
| 59 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.66901620 |
| 60 | synaptic vesicle endocytosis (GO:0048488) | 2.66660796 |
| 61 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.66634512 |
| 62 | neuronal action potential propagation (GO:0019227) | 2.65753475 |
| 63 | gamma-aminobutyric acid transport (GO:0015812) | 2.65477122 |
| 64 | fucose catabolic process (GO:0019317) | 2.65170745 |
| 65 | L-fucose metabolic process (GO:0042354) | 2.65170745 |
| 66 | L-fucose catabolic process (GO:0042355) | 2.65170745 |
| 67 | positive regulation of synapse maturation (GO:0090129) | 2.64821871 |
| 68 | cardiac muscle contraction (GO:0060048) | 2.64511509 |
| 69 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.63018433 |
| 70 | insulin secretion (GO:0030073) | 2.62858634 |
| 71 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.62309449 |
| 72 | carnitine shuttle (GO:0006853) | 2.60420635 |
| 73 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.57142715 |
| 74 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.56533017 |
| 75 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.55621760 |
| 76 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.54699260 |
| 77 | long-term memory (GO:0007616) | 2.53952338 |
| 78 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.52353357 |
| 79 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.52353357 |
| 80 | presynaptic membrane organization (GO:0097090) | 2.51833512 |
| 81 | positive regulation of sodium ion transport (GO:0010765) | 2.51645400 |
| 82 | membrane repolarization (GO:0086009) | 2.51236169 |
| 83 | cellular sodium ion homeostasis (GO:0006883) | 2.50663095 |
| 84 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.50085062 |
| 85 | alanine transport (GO:0032328) | 2.49730495 |
| 86 | synaptic transmission, glutamatergic (GO:0035249) | 2.49648592 |
| 87 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.49548833 |
| 88 | inositol phosphate dephosphorylation (GO:0046855) | 2.49155406 |
| 89 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.49155406 |
| 90 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.48184080 |
| 91 | establishment of nucleus localization (GO:0040023) | 2.47655446 |
| 92 | myofibril assembly (GO:0030239) | 2.47283113 |
| 93 | startle response (GO:0001964) | 2.45896793 |
| 94 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.45792417 |
| 95 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.45692130 |
| 96 | membrane depolarization during action potential (GO:0086010) | 2.44991394 |
| 97 | keratinocyte development (GO:0003334) | 2.43138459 |
| 98 | regulation of postsynaptic membrane potential (GO:0060078) | 2.43137245 |
| 99 | cardiac conduction (GO:0061337) | 2.42188468 |
| 100 | glutamate receptor signaling pathway (GO:0007215) | 2.41369094 |
| 101 | sarcomere organization (GO:0045214) | 2.40054206 |
| 102 | dendrite morphogenesis (GO:0048813) | 2.39495294 |
| 103 | chemosensory behavior (GO:0007635) | 2.39285125 |
| 104 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.38881281 |
| 105 | polyol catabolic process (GO:0046174) | 2.38878102 |
| 106 | membrane repolarization during action potential (GO:0086011) | 2.38448510 |
| 107 | positive regulation of membrane potential (GO:0045838) | 2.38031657 |
| 108 | protein targeting to Golgi (GO:0000042) | 2.37992478 |
| 109 | regulation of autophagic vacuole assembly (GO:2000785) | 2.37704668 |
| 110 | regulation of synaptic plasticity (GO:0048167) | 2.37622791 |
| 111 | glycine transport (GO:0015816) | 2.37039904 |
| 112 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.36588399 |
| 113 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.36588399 |
| 114 | fatty acid transmembrane transport (GO:1902001) | 2.36542469 |
| 115 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.36444678 |
| 116 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.36432960 |
| 117 | regulation of neurotransmitter uptake (GO:0051580) | 2.36177138 |
| 118 | cerebellar granule cell differentiation (GO:0021707) | 2.36065293 |
| 119 | neuronal action potential (GO:0019228) | 2.35363365 |
| 120 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.35332461 |
| 121 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.35332461 |
| 122 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.35332461 |
| 123 | dentate gyrus development (GO:0021542) | 2.34692231 |
| 124 | potassium ion homeostasis (GO:0055075) | 2.34660591 |
| 125 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.33838164 |
| 126 | cerebellar Purkinje cell layer development (GO:0021680) | 2.33719233 |
| 127 | detection of calcium ion (GO:0005513) | 2.32722931 |
| 128 | negative regulation of cell size (GO:0045792) | 2.32678904 |
| 129 | glycosphingolipid biosynthetic process (GO:0006688) | 2.31338138 |
| 130 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.30225744 |
| 131 | neuromuscular synaptic transmission (GO:0007274) | 2.30192275 |
| 132 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.29006630 |
| 133 | serotonin metabolic process (GO:0042428) | 2.28724162 |
| 134 | establishment of protein localization to Golgi (GO:0072600) | 2.28617497 |
| 135 | behavioral response to nicotine (GO:0035095) | 2.28435450 |
| 136 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.27659495 |
| 137 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.27659495 |
| 138 | postsynaptic membrane organization (GO:0001941) | 2.25773593 |
| 139 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.23245229 |
| 140 | primary amino compound metabolic process (GO:1901160) | 2.21348892 |
| 141 | reflex (GO:0060004) | 2.20211144 |
| 142 | cyclic nucleotide catabolic process (GO:0009214) | 2.18374966 |
| 143 | regulation of action potential (GO:0098900) | 2.18282869 |
| 144 | long-term synaptic potentiation (GO:0060291) | 2.16075522 |
| 145 | kidney morphogenesis (GO:0060993) | 2.15340180 |
| 146 | negative regulation of dendrite development (GO:2000171) | 2.14964541 |
| 147 | auditory receptor cell stereocilium organization (GO:0060088) | 2.14705840 |
| 148 | response to gravity (GO:0009629) | 2.14599547 |
| 149 | activated T cell proliferation (GO:0050798) | 2.14249479 |
| 150 | potassium ion transport (GO:0006813) | 2.13770588 |
| 151 | positive regulation of meiosis (GO:0045836) | 2.13730287 |
| 152 | cellular ketone body metabolic process (GO:0046950) | 2.13650061 |
| 153 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.13389932 |
| 154 | regulation of vacuole organization (GO:0044088) | 2.13131836 |
| 155 | protein localization to Golgi apparatus (GO:0034067) | 2.12405944 |
| 156 | Golgi to endosome transport (GO:0006895) | 2.12184556 |
| 157 | positive regulation of granulocyte differentiation (GO:0030854) | 2.12182375 |
| 158 | long term synaptic depression (GO:0060292) | 2.11970218 |
| 159 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.11522941 |
| 160 | positive regulation of insulin secretion (GO:0032024) | 2.10501500 |
| 161 | negative regulation of protein autophosphorylation (GO:0031953) | 2.10481032 |
| 162 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.09597536 |
| 163 | nitric oxide mediated signal transduction (GO:0007263) | 2.08534063 |
| 164 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.08182066 |
| 165 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.07610347 |
| 166 | cAMP catabolic process (GO:0006198) | 2.07404496 |
| 167 | axoneme assembly (GO:0035082) | 2.06593661 |
| 168 | cellular potassium ion transport (GO:0071804) | 2.05420076 |
| 169 | potassium ion transmembrane transport (GO:0071805) | 2.05420076 |
| 170 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.04719834 |
| 171 | positive regulation of mRNA catabolic process (GO:0061014) | 2.04712911 |
| 172 | epithelial cell fate commitment (GO:0072148) | 2.04118022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.02668410 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.95733817 |
| 3 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.45774772 |
| 4 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.34743141 |
| 5 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.33090367 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.11099245 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.08640951 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.06333510 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.00055504 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.00055504 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.99396546 |
| 12 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.98431631 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.93343009 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.86158187 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.84735986 |
| 16 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.83876960 |
| 17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.82390664 |
| 18 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.81869764 |
| 19 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.81283862 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.80952275 |
| 21 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.79913861 |
| 22 | KDM2B_26808549_Chip-Seq_K562_Human | 1.79243150 |
| 23 | VDR_22108803_ChIP-Seq_LS180_Human | 1.77577313 |
| 24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.76009533 |
| 25 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.74637518 |
| 26 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.74551297 |
| 27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.72159557 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.70084859 |
| 29 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.69767485 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.67260990 |
| 31 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.67208853 |
| 32 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.64588138 |
| 33 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.64550958 |
| 34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.63849997 |
| 35 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.62763471 |
| 36 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.61691377 |
| 37 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.58735137 |
| 38 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.56986224 |
| 39 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.56880260 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.56539514 |
| 41 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.56440761 |
| 42 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.56418415 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.55385327 |
| 44 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.54705928 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.54290281 |
| 46 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.52272575 |
| 47 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.52079373 |
| 48 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.51384837 |
| 49 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.50545045 |
| 50 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.50434896 |
| 51 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.47931666 |
| 52 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.44697158 |
| 53 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.44041436 |
| 54 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.43408004 |
| 55 | AR_25329375_ChIP-Seq_VCAP_Human | 1.42297193 |
| 56 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.42290131 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.41440542 |
| 58 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.41344748 |
| 59 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.39802798 |
| 60 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.39521651 |
| 61 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.39201325 |
| 62 | P300_19829295_ChIP-Seq_ESCs_Human | 1.36408807 |
| 63 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.36289800 |
| 64 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35918939 |
| 65 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.34199829 |
| 66 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.33931165 |
| 67 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.33315423 |
| 68 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.31973009 |
| 69 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.30392992 |
| 70 | TCF4_23295773_ChIP-Seq_U87_Human | 1.30297379 |
| 71 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.29616220 |
| 72 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28981447 |
| 73 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.28142491 |
| 74 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.27356092 |
| 75 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26304857 |
| 76 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.25700466 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.25376144 |
| 78 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.25241247 |
| 79 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25050678 |
| 80 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.22037610 |
| 81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.20849788 |
| 82 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.20569068 |
| 83 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20569068 |
| 84 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20129599 |
| 85 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.19824354 |
| 86 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.18238028 |
| 87 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.17788874 |
| 88 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.17703790 |
| 89 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.17424761 |
| 90 | FUS_26573619_Chip-Seq_HEK293_Human | 1.16975800 |
| 91 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.16633775 |
| 92 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.16633775 |
| 93 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16433736 |
| 94 | AR_19668381_ChIP-Seq_PC3_Human | 1.16402549 |
| 95 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.16306168 |
| 96 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.16227105 |
| 97 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.15792831 |
| 98 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.15418728 |
| 99 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.14904839 |
| 100 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14292202 |
| 101 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13368729 |
| 102 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.12778526 |
| 103 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.12743509 |
| 104 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.12743509 |
| 105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.12390415 |
| 106 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12227659 |
| 107 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10908387 |
| 108 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.10664030 |
| 109 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.10495712 |
| 110 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10383203 |
| 111 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.10206465 |
| 112 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10012366 |
| 113 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09084315 |
| 114 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.08920683 |
| 115 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.08610014 |
| 116 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.08310869 |
| 117 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.07575875 |
| 118 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.07502030 |
| 119 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07292075 |
| 120 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.06913566 |
| 121 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.06781612 |
| 122 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06128672 |
| 123 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05932408 |
| 124 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.05640354 |
| 125 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04553780 |
| 126 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03451676 |
| 127 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.02325038 |
| 128 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02082631 |
| 129 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01626695 |
| 130 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01540732 |
| 131 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00717165 |
| 132 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.00611435 |
| 133 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00465174 |
| 134 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.00334443 |
| 135 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99655296 |
| 136 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99134563 |
| 137 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98999373 |
| 138 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.98915557 |
| 139 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98914096 |
| 140 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98018557 |
| 141 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.97664651 |
| 142 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97304402 |
| 143 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.96772875 |
| 144 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95473073 |
| 145 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.94848536 |
| 146 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.94428425 |
| 147 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94228235 |
| 148 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.93696151 |
| 149 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.93229116 |
| 150 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.91940642 |
| 151 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91765786 |
| 152 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.91721761 |
| 153 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.91721761 |
| 154 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91704302 |
| 155 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91325159 |
| 156 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.91040404 |
| 157 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90576890 |
| 158 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.89657658 |
| 159 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.88568884 |
| 160 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87779487 |
| 161 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.87602448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.42520534 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 3.42025292 |
| 3 | MP0000751_myopathy | 3.07422884 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.01408495 |
| 5 | MP0003787_abnormal_imprinting | 2.83555426 |
| 6 | MP0004270_analgesia | 2.79334395 |
| 7 | MP0009780_abnormal_chondrocyte_physiolo | 2.59986414 |
| 8 | MP0003646_muscle_fatigue | 2.59723097 |
| 9 | MP0003195_calcinosis | 2.38904313 |
| 10 | MP0005646_abnormal_pituitary_gland | 2.35590643 |
| 11 | MP0002063_abnormal_learning/memory/cond | 2.31932954 |
| 12 | MP0004130_abnormal_muscle_cell | 2.26677749 |
| 13 | MP0002876_abnormal_thyroid_physiology | 2.26135327 |
| 14 | MP0002909_abnormal_adrenal_gland | 2.25264668 |
| 15 | MP0004084_abnormal_cardiac_muscle | 2.14709082 |
| 16 | MP0008961_abnormal_basal_metabolism | 2.10748108 |
| 17 | MP0004215_abnormal_myocardial_fiber | 2.09989497 |
| 18 | MP0009745_abnormal_behavioral_response | 2.09498268 |
| 19 | MP0002064_seizures | 2.07843977 |
| 20 | MP0003880_abnormal_central_pattern | 1.98266062 |
| 21 | MP0009046_muscle_twitch | 1.92592532 |
| 22 | MP0004036_abnormal_muscle_relaxation | 1.90976263 |
| 23 | MP0004858_abnormal_nervous_system | 1.87520250 |
| 24 | MP0010386_abnormal_urinary_bladder | 1.86806476 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 1.81349312 |
| 26 | MP0002822_catalepsy | 1.78159020 |
| 27 | MP0001984_abnormal_olfaction | 1.77774939 |
| 28 | MP0003329_amyloid_beta_deposits | 1.77222923 |
| 29 | MP0004087_abnormal_muscle_fiber | 1.75436999 |
| 30 | MP0004510_myositis | 1.75426124 |
| 31 | MP0004145_abnormal_muscle_electrophysio | 1.74438789 |
| 32 | MP0002572_abnormal_emotion/affect_behav | 1.72845507 |
| 33 | MP0005551_abnormal_eye_electrophysiolog | 1.71993287 |
| 34 | MP0002638_abnormal_pupillary_reflex | 1.69915709 |
| 35 | MP0004233_abnormal_muscle_weight | 1.69782960 |
| 36 | MP0005645_abnormal_hypothalamus_physiol | 1.60797955 |
| 37 | MP0000749_muscle_degeneration | 1.59696117 |
| 38 | MP0008569_lethality_at_weaning | 1.58439795 |
| 39 | MP0005330_cardiomyopathy | 1.54939522 |
| 40 | MP0008872_abnormal_physiological_respon | 1.53229350 |
| 41 | MP0001486_abnormal_startle_reflex | 1.45293413 |
| 42 | MP0005620_abnormal_muscle_contractility | 1.44954324 |
| 43 | MP0000569_abnormal_digit_pigmentation | 1.44289540 |
| 44 | MP0004085_abnormal_heartbeat | 1.43740260 |
| 45 | MP0002269_muscular_atrophy | 1.41708150 |
| 46 | MP0001501_abnormal_sleep_pattern | 1.40778763 |
| 47 | MP0003137_abnormal_impulse_conducting | 1.40331721 |
| 48 | MP0003879_abnormal_hair_cell | 1.38929924 |
| 49 | MP0002734_abnormal_mechanical_nocicepti | 1.36924241 |
| 50 | MP0004885_abnormal_endolymph | 1.36418546 |
| 51 | MP0002272_abnormal_nervous_system | 1.36188836 |
| 52 | MP0000747_muscle_weakness | 1.36176781 |
| 53 | MP0002693_abnormal_pancreas_physiology | 1.36175890 |
| 54 | MP0001944_abnormal_pancreas_morphology | 1.35164567 |
| 55 | MP0002972_abnormal_cardiac_muscle | 1.33386221 |
| 56 | MP0004381_abnormal_hair_follicle | 1.33362744 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 1.33282335 |
| 58 | MP0004484_altered_response_of | 1.31303990 |
| 59 | MP0001905_abnormal_dopamine_level | 1.31183947 |
| 60 | MP0006072_abnormal_retinal_apoptosis | 1.30149849 |
| 61 | MP0008877_abnormal_DNA_methylation | 1.29113573 |
| 62 | MP0002106_abnormal_muscle_physiology | 1.29104147 |
| 63 | MP0004185_abnormal_adipocyte_glucose | 1.29024183 |
| 64 | MP0001440_abnormal_grooming_behavior | 1.28746157 |
| 65 | MP0001968_abnormal_touch/_nociception | 1.28278836 |
| 66 | MP0005423_abnormal_somatic_nervous | 1.27918643 |
| 67 | MP0005365_abnormal_bile_salt | 1.26723270 |
| 68 | MP0005379_endocrine/exocrine_gland_phen | 1.26125075 |
| 69 | MP0001986_abnormal_taste_sensitivity | 1.25394699 |
| 70 | MP0005085_abnormal_gallbladder_physiolo | 1.24472024 |
| 71 | MP0001485_abnormal_pinna_reflex | 1.23869004 |
| 72 | MP0002735_abnormal_chemical_nociception | 1.23674977 |
| 73 | MP0004811_abnormal_neuron_physiology | 1.23460260 |
| 74 | MP0003633_abnormal_nervous_system | 1.23458300 |
| 75 | MP0010630_abnormal_cardiac_muscle | 1.22083621 |
| 76 | MP0005174_abnormal_tail_pigmentation | 1.21487096 |
| 77 | MP0000759_abnormal_skeletal_muscle | 1.20566906 |
| 78 | MP0002928_abnormal_bile_duct | 1.19555604 |
| 79 | MP0000631_abnormal_neuroendocrine_gland | 1.18518553 |
| 80 | MP0003075_altered_response_to | 1.18338643 |
| 81 | MP0005360_urolithiasis | 1.17486748 |
| 82 | MP0002102_abnormal_ear_morphology | 1.14328161 |
| 83 | MP0006138_congestive_heart_failure | 1.14196983 |
| 84 | MP0005253_abnormal_eye_physiology | 1.14005580 |
| 85 | MP0004043_abnormal_pH_regulation | 1.13907074 |
| 86 | MP0003252_abnormal_bile_duct | 1.12009290 |
| 87 | MP0002139_abnormal_hepatobiliary_system | 1.11895750 |
| 88 | MP0004924_abnormal_behavior | 1.11128847 |
| 89 | MP0005386_behavior/neurological_phenoty | 1.11128847 |
| 90 | MP0000750_abnormal_muscle_regeneration | 1.10539091 |
| 91 | MP0000427_abnormal_hair_cycle | 1.09155522 |
| 92 | MP0005187_abnormal_penis_morphology | 1.07713171 |
| 93 | MP0008874_decreased_physiological_sensi | 1.07622391 |
| 94 | MP0005369_muscle_phenotype | 1.07547390 |
| 95 | MP0008775_abnormal_heart_ventricle | 1.06894817 |
| 96 | MP0002009_preneoplasia | 1.06870890 |
| 97 | MP0002067_abnormal_sensory_capabilities | 1.06718922 |
| 98 | MP0005623_abnormal_meninges_morphology | 1.04769326 |
| 99 | MP0005666_abnormal_adipose_tissue | 1.04437756 |
| 100 | MP0010329_abnormal_lipoprotein_level | 1.03356999 |
| 101 | MP0005385_cardiovascular_system_phenoty | 1.02542036 |
| 102 | MP0001544_abnormal_cardiovascular_syste | 1.02542036 |
| 103 | MP0002736_abnormal_nociception_after | 1.01623223 |
| 104 | MP0000516_abnormal_urinary_system | 1.01146256 |
| 105 | MP0005367_renal/urinary_system_phenotyp | 1.01146256 |
| 106 | MP0003045_fibrosis | 1.00775472 |
| 107 | MP0003724_increased_susceptibility_to | 1.00731811 |
| 108 | MP0001756_abnormal_urination | 1.00628212 |
| 109 | MP0003283_abnormal_digestive_organ | 1.00130113 |
| 110 | MP0002733_abnormal_thermal_nociception | 0.98774955 |
| 111 | MP0000538_abnormal_urinary_bladder | 0.98557105 |
| 112 | MP0005220_abnormal_exocrine_pancreas | 0.98175788 |
| 113 | MP0003172_abnormal_lysosome_physiology | 0.97539060 |
| 114 | MP0002090_abnormal_vision | 0.97516701 |
| 115 | MP0005535_abnormal_body_temperature | 0.97467276 |
| 116 | MP0005167_abnormal_blood-brain_barrier | 0.97248125 |
| 117 | MP0002166_altered_tumor_susceptibility | 0.96959399 |
| 118 | MP0004142_abnormal_muscle_tone | 0.96074664 |
| 119 | MP0000015_abnormal_ear_pigmentation | 0.95900654 |
| 120 | MP0002234_abnormal_pharynx_morphology | 0.94471821 |
| 121 | MP0002066_abnormal_motor_capabilities/c | 0.93910556 |
| 122 | MP0005375_adipose_tissue_phenotype | 0.92397678 |
| 123 | MP0003690_abnormal_glial_cell | 0.91435040 |
| 124 | MP0002163_abnormal_gland_morphology | 0.91404577 |
| 125 | MP0002138_abnormal_hepatobiliary_system | 0.91306875 |
| 126 | MP0001970_abnormal_pain_threshold | 0.91226100 |
| 127 | MP0001765_abnormal_ion_homeostasis | 0.90739579 |
| 128 | MP0000604_amyloidosis | 0.90703537 |
| 129 | MP0000955_abnormal_spinal_cord | 0.89212910 |
| 130 | MP0002229_neurodegeneration | 0.88835670 |
| 131 | MP0006276_abnormal_autonomic_nervous | 0.88723214 |
| 132 | MP0003631_nervous_system_phenotype | 0.87676998 |
| 133 | MP0001502_abnormal_circadian_rhythm | 0.87543330 |
| 134 | MP0002557_abnormal_social/conspecific_i | 0.85650424 |
| 135 | MP0002108_abnormal_muscle_morphology | 0.84006560 |
| 136 | MP0000230_abnormal_systemic_arterial | 0.83827053 |
| 137 | MP0010234_abnormal_vibrissa_follicle | 0.83543757 |
| 138 | MP0002882_abnormal_neuron_morphology | 0.82545453 |
| 139 | MP0005448_abnormal_energy_balance | 0.82462811 |
| 140 | MP0000003_abnormal_adipose_tissue | 0.82055302 |
| 141 | MP0005076_abnormal_cell_differentiation | 0.81587169 |
| 142 | MP0003303_peritoneal_inflammation | 0.81166301 |
| 143 | MP0000013_abnormal_adipose_tissue | 0.79722184 |
| 144 | MP0002078_abnormal_glucose_homeostasis | 0.79239937 |
| 145 | MP0002118_abnormal_lipid_homeostasis | 0.76904218 |
| 146 | MP0002184_abnormal_innervation | 0.75805396 |
| 147 | MP0003953_abnormal_hormone_level | 0.73718639 |
| 148 | MP0000639_abnormal_adrenal_gland | 0.73332908 |
| 149 | MP0003763_abnormal_thymus_physiology | 0.73322632 |
| 150 | MP0002277_abnormal_respiratory_mucosa | 0.72501741 |
| 151 | MP0008995_early_reproductive_senescence | 0.72092451 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypothermia (HP:0002045) | 4.02981290 |
| 2 | Focal motor seizures (HP:0011153) | 3.90984058 |
| 3 | Sudden death (HP:0001699) | 3.85042533 |
| 4 | Bundle branch block (HP:0011710) | 3.63597291 |
| 5 | Dysmetric saccades (HP:0000641) | 3.62000272 |
| 6 | Exercise-induced myalgia (HP:0003738) | 3.59242322 |
| 7 | Visual hallucinations (HP:0002367) | 3.55761486 |
| 8 | Myokymia (HP:0002411) | 3.54444542 |
| 9 | Focal seizures (HP:0007359) | 3.44310114 |
| 10 | Hemiparesis (HP:0001269) | 3.29204010 |
| 11 | Ventricular fibrillation (HP:0001663) | 3.27131207 |
| 12 | Abnormality of the lower motor neuron (HP:0002366) | 3.08602144 |
| 13 | Pancreatic cysts (HP:0001737) | 3.03217470 |
| 14 | Exercise-induced muscle cramps (HP:0003710) | 2.84971750 |
| 15 | Abnormality of the renal cortex (HP:0011035) | 2.84464508 |
| 16 | Thyroiditis (HP:0100646) | 2.82821349 |
| 17 | Syncope (HP:0001279) | 2.82537002 |
| 18 | Absent speech (HP:0001344) | 2.81118402 |
| 19 | Impaired social interactions (HP:0000735) | 2.80217749 |
| 20 | Abnormal social behavior (HP:0012433) | 2.80217749 |
| 21 | Genetic anticipation (HP:0003743) | 2.80210191 |
| 22 | Action tremor (HP:0002345) | 2.79547210 |
| 23 | Epileptic encephalopathy (HP:0200134) | 2.74454659 |
| 24 | Hyporeflexia of lower limbs (HP:0002600) | 2.73705444 |
| 25 | Atrial fibrillation (HP:0005110) | 2.72353044 |
| 26 | Congenital stationary night blindness (HP:0007642) | 2.65809174 |
| 27 | Primary atrial arrhythmia (HP:0001692) | 2.64410693 |
| 28 | Poor eye contact (HP:0000817) | 2.64251024 |
| 29 | Difficulty running (HP:0009046) | 2.64058724 |
| 30 | Pancreatic fibrosis (HP:0100732) | 2.64044767 |
| 31 | Dysdiadochokinesis (HP:0002075) | 2.63103289 |
| 32 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.61613635 |
| 33 | Heart block (HP:0012722) | 2.60772663 |
| 34 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.60226839 |
| 35 | Nephronophthisis (HP:0000090) | 2.58637920 |
| 36 | Postural instability (HP:0002172) | 2.56951240 |
| 37 | Atrioventricular block (HP:0001678) | 2.54946990 |
| 38 | Generalized tonic-clonic seizures (HP:0002069) | 2.51188621 |
| 39 | Type II lissencephaly (HP:0007260) | 2.50210548 |
| 40 | Hematochezia (HP:0002573) | 2.50073390 |
| 41 | Depression (HP:0000716) | 2.47567529 |
| 42 | Calf muscle hypertrophy (HP:0008981) | 2.45774588 |
| 43 | Widely spaced teeth (HP:0000687) | 2.45197667 |
| 44 | Large for gestational age (HP:0001520) | 2.44476143 |
| 45 | Absence seizures (HP:0002121) | 2.44125396 |
| 46 | Ventricular arrhythmia (HP:0004308) | 2.43577760 |
| 47 | Prolonged QT interval (HP:0001657) | 2.43150284 |
| 48 | Supraventricular tachycardia (HP:0004755) | 2.41968834 |
| 49 | Abnormal atrioventricular conduction (HP:0005150) | 2.40830176 |
| 50 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.39834349 |
| 51 | Ventricular tachycardia (HP:0004756) | 2.39342695 |
| 52 | Myoglobinuria (HP:0002913) | 2.38390358 |
| 53 | Renal cortical cysts (HP:0000803) | 2.38015307 |
| 54 | Supraventricular arrhythmia (HP:0005115) | 2.37360686 |
| 55 | True hermaphroditism (HP:0010459) | 2.37045762 |
| 56 | Abnormality of the renal medulla (HP:0100957) | 2.36534282 |
| 57 | Asymmetric septal hypertrophy (HP:0001670) | 2.36295701 |
| 58 | Macroorchidism (HP:0000053) | 2.35728121 |
| 59 | Aqueductal stenosis (HP:0002410) | 2.34743920 |
| 60 | Atonic seizures (HP:0010819) | 2.34472115 |
| 61 | Abnormality of the calf musculature (HP:0001430) | 2.32803286 |
| 62 | Attenuation of retinal blood vessels (HP:0007843) | 2.32494589 |
| 63 | Progressive cerebellar ataxia (HP:0002073) | 2.32208643 |
| 64 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.31278762 |
| 65 | Hemiplegia (HP:0002301) | 2.30058926 |
| 66 | Neoplasm of the adrenal cortex (HP:0100641) | 2.29798583 |
| 67 | Ketoacidosis (HP:0001993) | 2.28851388 |
| 68 | Cystic liver disease (HP:0006706) | 2.28839292 |
| 69 | Supranuclear gaze palsy (HP:0000605) | 2.26516985 |
| 70 | Muscle fiber splitting (HP:0003555) | 2.23451007 |
| 71 | Abnormal drinking behavior (HP:0030082) | 2.21441536 |
| 72 | Polydipsia (HP:0001959) | 2.21441536 |
| 73 | Epileptiform EEG discharges (HP:0011182) | 2.21281302 |
| 74 | Right ventricular cardiomyopathy (HP:0011663) | 2.19390070 |
| 75 | Congenital sensorineural hearing impairment (HP:0008527) | 2.18605917 |
| 76 | Febrile seizures (HP:0002373) | 2.18179894 |
| 77 | Subaortic stenosis (HP:0001682) | 2.16336544 |
| 78 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.16336544 |
| 79 | Lower limb amyotrophy (HP:0007210) | 2.14650500 |
| 80 | Increased variability in muscle fiber diameter (HP:0003557) | 2.14589524 |
| 81 | Abnormal EKG (HP:0003115) | 2.14309322 |
| 82 | EEG with generalized epileptiform discharges (HP:0011198) | 2.11720734 |
| 83 | Myotonia (HP:0002486) | 2.11581410 |
| 84 | Status epilepticus (HP:0002133) | 2.10950630 |
| 85 | Dialeptic seizures (HP:0011146) | 2.10895940 |
| 86 | EMG: myopathic abnormalities (HP:0003458) | 2.09164670 |
| 87 | Hyperventilation (HP:0002883) | 2.06669517 |
| 88 | Clumsiness (HP:0002312) | 2.06293648 |
| 89 | Broad-based gait (HP:0002136) | 2.04681431 |
| 90 | Increased corneal curvature (HP:0100692) | 2.04540983 |
| 91 | Keratoconus (HP:0000563) | 2.04540983 |
| 92 | Papilledema (HP:0001085) | 2.04136067 |
| 93 | Lymphangioma (HP:0100764) | 2.02172000 |
| 94 | Generalized hypopigmentation of hair (HP:0011358) | 2.02022169 |
| 95 | Hypsarrhythmia (HP:0002521) | 2.01368762 |
| 96 | Rapidly progressive (HP:0003678) | 2.01271940 |
| 97 | Dysmetria (HP:0001310) | 2.00494034 |
| 98 | Decreased central vision (HP:0007663) | 2.00464446 |
| 99 | Ankle clonus (HP:0011448) | 1.99865555 |
| 100 | Urinary urgency (HP:0000012) | 1.99140040 |
| 101 | Abnormality of the Achilles tendon (HP:0005109) | 1.98449585 |
| 102 | Stomatitis (HP:0010280) | 1.97363249 |
| 103 | Diplopia (HP:0000651) | 1.96986244 |
| 104 | Abnormality of binocular vision (HP:0011514) | 1.96986244 |
| 105 | Resting tremor (HP:0002322) | 1.96401057 |
| 106 | Molar tooth sign on MRI (HP:0002419) | 1.95999302 |
| 107 | Abnormality of midbrain morphology (HP:0002418) | 1.95999302 |
| 108 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.95878138 |
| 109 | Obstructive sleep apnea (HP:0002870) | 1.95659280 |
| 110 | Deep venous thrombosis (HP:0002625) | 1.95575622 |
| 111 | Increased connective tissue (HP:0009025) | 1.95154195 |
| 112 | Gaze-evoked nystagmus (HP:0000640) | 1.95117908 |
| 113 | Central scotoma (HP:0000603) | 1.95095413 |
| 114 | Fair hair (HP:0002286) | 1.94848265 |
| 115 | Tongue fasciculations (HP:0001308) | 1.94761235 |
| 116 | Furrowed tongue (HP:0000221) | 1.94487220 |
| 117 | Torticollis (HP:0000473) | 1.94003519 |
| 118 | Conjunctival hamartoma (HP:0100780) | 1.93951970 |
| 119 | Hamartoma of the eye (HP:0010568) | 1.93788827 |
| 120 | Achilles tendon contracture (HP:0001771) | 1.93732867 |
| 121 | Ketosis (HP:0001946) | 1.92762994 |
| 122 | EMG: neuropathic changes (HP:0003445) | 1.92679076 |
| 123 | Hyperglycemia (HP:0003074) | 1.92642039 |
| 124 | Cerebral inclusion bodies (HP:0100314) | 1.92292752 |
| 125 | Agitation (HP:0000713) | 1.91694905 |
| 126 | Impaired smooth pursuit (HP:0007772) | 1.90551478 |
| 127 | Anxiety (HP:0000739) | 1.89687070 |
| 128 | Global brain atrophy (HP:0002283) | 1.88195747 |
| 129 | Gout (HP:0001997) | 1.87373440 |
| 130 | Increased circulating renin level (HP:0000848) | 1.87144890 |
| 131 | Intellectual disability, progressive (HP:0006887) | 1.84329982 |
| 132 | Distal upper limb amyotrophy (HP:0007149) | 1.84062804 |
| 133 | Upper limb amyotrophy (HP:0009129) | 1.84062804 |
| 134 | Difficulty climbing stairs (HP:0003551) | 1.83504529 |
| 135 | Impaired vibratory sensation (HP:0002495) | 1.82661230 |
| 136 | Hypoglycemic coma (HP:0001325) | 1.82463115 |
| 137 | Insomnia (HP:0100785) | 1.82251855 |
| 138 | Hypoplasia of the odontoid process (HP:0003311) | 1.82165042 |
| 139 | Hypomagnesemia (HP:0002917) | 1.81430238 |
| 140 | Abolished electroretinogram (ERG) (HP:0000550) | 1.81422143 |
| 141 | Hyperacusis (HP:0010780) | 1.80685513 |
| 142 | Tubular atrophy (HP:0000092) | 1.80496033 |
| 143 | Cerebral aneurysm (HP:0004944) | 1.80463878 |
| 144 | Tented upper lip vermilion (HP:0010804) | 1.80362911 |
| 145 | Neoplasm of the heart (HP:0100544) | 1.80060217 |
| 146 | Testicular neoplasm (HP:0010788) | 1.79647170 |
| 147 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.79338589 |
| 148 | Medial flaring of the eyebrow (HP:0010747) | 1.79196466 |
| 149 | Muscle fibrillation (HP:0010546) | 1.78709658 |
| 150 | Pachygyria (HP:0001302) | 1.78503609 |
| 151 | Stomach cancer (HP:0012126) | 1.78202164 |
| 152 | Excessive salivation (HP:0003781) | 1.74751946 |
| 153 | Drooling (HP:0002307) | 1.74751946 |
| 154 | Intention tremor (HP:0002080) | 1.74700678 |
| 155 | Termporal pattern (HP:0011008) | 1.74644134 |
| 156 | Insidious onset (HP:0003587) | 1.74644134 |
| 157 | Increased CSF protein (HP:0002922) | 1.73918636 |
| 158 | Enlarged penis (HP:0000040) | 1.73157990 |
| 159 | Protruding tongue (HP:0010808) | 1.72964730 |
| 160 | Blue irides (HP:0000635) | 1.72028484 |
| 161 | Hypoplastic ischia (HP:0003175) | 1.71446647 |
| 162 | Intestinal atresia (HP:0011100) | 1.71110767 |
| 163 | Late onset (HP:0003584) | 1.70164301 |
| 164 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.68387049 |
| 165 | Decreased circulating renin level (HP:0003351) | 1.66090874 |
| 166 | Abnormality of the columella (HP:0009929) | 1.65184624 |
| 167 | Inability to walk (HP:0002540) | 1.64675277 |
| 168 | Hypoplastic iliac wings (HP:0002866) | 1.64553862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.31477815 |
| 2 | TRIB3 | 2.96133587 |
| 3 | MAP3K9 | 2.91658330 |
| 4 | EPHA4 | 2.80776189 |
| 5 | DAPK2 | 2.62544008 |
| 6 | PRKD3 | 2.44596345 |
| 7 | NTRK3 | 2.33014884 |
| 8 | PAK6 | 2.30164467 |
| 9 | MAP3K4 | 2.29508675 |
| 10 | BMPR1B | 2.01608654 |
| 11 | TAOK1 | 1.96071466 |
| 12 | RIPK1 | 1.93864589 |
| 13 | TNK2 | 1.89254752 |
| 14 | MAP4K2 | 1.86181346 |
| 15 | KSR2 | 1.85000915 |
| 16 | CAMKK1 | 1.82589968 |
| 17 | MAP2K4 | 1.77993877 |
| 18 | STK38 | 1.74489830 |
| 19 | PKN2 | 1.73660810 |
| 20 | MAPK13 | 1.73329934 |
| 21 | CASK | 1.70227690 |
| 22 | DMPK | 1.66277646 |
| 23 | TTN | 1.65587013 |
| 24 | GRK1 | 1.64345036 |
| 25 | TYRO3 | 1.63015636 |
| 26 | PHKG2 | 1.62647841 |
| 27 | PHKG1 | 1.62647841 |
| 28 | TAOK3 | 1.62334536 |
| 29 | CAMK1G | 1.57225115 |
| 30 | ADRBK2 | 1.55914998 |
| 31 | SIK2 | 1.55721440 |
| 32 | MINK1 | 1.46548436 |
| 33 | ICK | 1.45232887 |
| 34 | TXK | 1.40364161 |
| 35 | MARK1 | 1.40102608 |
| 36 | TNIK | 1.36607685 |
| 37 | PDGFRA | 1.36308136 |
| 38 | NLK | 1.35224026 |
| 39 | NEK1 | 1.33779202 |
| 40 | LMTK2 | 1.30754890 |
| 41 | MAP3K7 | 1.29364682 |
| 42 | HIPK2 | 1.25534107 |
| 43 | NTRK2 | 1.25036832 |
| 44 | PRKCH | 1.22565873 |
| 45 | NTRK1 | 1.21499472 |
| 46 | SGK3 | 1.19460743 |
| 47 | PINK1 | 1.17126594 |
| 48 | LATS2 | 1.16570777 |
| 49 | MARK3 | 1.15756552 |
| 50 | RIPK4 | 1.13892823 |
| 51 | SIK1 | 1.12823340 |
| 52 | DAPK1 | 1.12301596 |
| 53 | OXSR1 | 1.11103942 |
| 54 | CDK12 | 1.10605003 |
| 55 | FGFR3 | 1.10265882 |
| 56 | AKT3 | 1.09987370 |
| 57 | RET | 1.09887226 |
| 58 | WNK3 | 1.07186730 |
| 59 | CAMK1D | 1.07182450 |
| 60 | STK11 | 1.04485646 |
| 61 | MAP2K7 | 1.03792294 |
| 62 | ERN1 | 1.02959264 |
| 63 | CDK5 | 1.02631185 |
| 64 | ALK | 1.00192601 |
| 65 | PRKCE | 0.97672646 |
| 66 | MAP2K6 | 0.97208824 |
| 67 | PAK3 | 0.95862834 |
| 68 | CAMK4 | 0.95828332 |
| 69 | KSR1 | 0.95547484 |
| 70 | CDC42BPA | 0.94415157 |
| 71 | MARK2 | 0.93754270 |
| 72 | TRPM7 | 0.93579409 |
| 73 | CAMK1 | 0.91935521 |
| 74 | MAP3K2 | 0.91182422 |
| 75 | DDR2 | 0.84416201 |
| 76 | PDPK1 | 0.83219203 |
| 77 | MUSK | 0.81411865 |
| 78 | PTK2B | 0.80693706 |
| 79 | SGK2 | 0.80224446 |
| 80 | LATS1 | 0.80044798 |
| 81 | PDK1 | 0.78979473 |
| 82 | ERBB3 | 0.78590183 |
| 83 | NUAK1 | 0.77013450 |
| 84 | WNK1 | 0.76430891 |
| 85 | GRK6 | 0.76323001 |
| 86 | PDK4 | 0.75217162 |
| 87 | PDK3 | 0.75217162 |
| 88 | MAP4K1 | 0.72833750 |
| 89 | STK39 | 0.72180105 |
| 90 | SGK494 | 0.72086663 |
| 91 | SGK223 | 0.72086663 |
| 92 | MAPK12 | 0.71719647 |
| 93 | MAP3K1 | 0.71352485 |
| 94 | SGK1 | 0.71080764 |
| 95 | CDK3 | 0.71022512 |
| 96 | ITK | 0.70779997 |
| 97 | PRPF4B | 0.70310130 |
| 98 | SIK3 | 0.67635742 |
| 99 | PRKCQ | 0.67387691 |
| 100 | EEF2K | 0.67358893 |
| 101 | MAPK7 | 0.67214572 |
| 102 | MAP3K10 | 0.66550977 |
| 103 | GRK5 | 0.66456137 |
| 104 | MAP3K6 | 0.66253699 |
| 105 | PRKAA1 | 0.66131479 |
| 106 | PRKD1 | 0.66081950 |
| 107 | PTK6 | 0.65969159 |
| 108 | BMX | 0.65613974 |
| 109 | UHMK1 | 0.64064422 |
| 110 | PRKD2 | 0.62176749 |
| 111 | PRKCG | 0.62141703 |
| 112 | WNK4 | 0.61725078 |
| 113 | PLK2 | 0.59578341 |
| 114 | CAMKK2 | 0.58862631 |
| 115 | CAMK2A | 0.58605114 |
| 116 | PTK2 | 0.58461909 |
| 117 | RPS6KA3 | 0.58067652 |
| 118 | MAP3K13 | 0.52970229 |
| 119 | INSRR | 0.52106342 |
| 120 | MTOR | 0.51901607 |
| 121 | CSNK1A1L | 0.50912778 |
| 122 | IRAK1 | 0.49960837 |
| 123 | OBSCN | 0.49324580 |
| 124 | PDGFRB | 0.48491013 |
| 125 | FES | 0.47769769 |
| 126 | MAPKAPK3 | 0.46831456 |
| 127 | ACVR1B | 0.46584810 |
| 128 | PRKCZ | 0.45981335 |
| 129 | CHUK | 0.45762150 |
| 130 | MAPK15 | 0.45557535 |
| 131 | DAPK3 | 0.44989553 |
| 132 | ROCK1 | 0.44987412 |
| 133 | CDK19 | 0.44542894 |
| 134 | CSNK1G2 | 0.44404712 |
| 135 | FGFR2 | 0.43695503 |
| 136 | PIK3CA | 0.42665748 |
| 137 | SYK | 0.42258260 |
| 138 | FER | 0.42249211 |
| 139 | CSNK1G3 | 0.41720002 |
| 140 | IKBKB | 0.41049845 |
| 141 | MAPK10 | 0.40867560 |
| 142 | CDK15 | 0.39701845 |
| 143 | PRKG1 | 0.39038137 |
| 144 | PRKCI | 0.38223543 |
| 145 | JAK1 | 0.37370651 |
| 146 | PRKAA2 | 0.36822043 |
| 147 | CDK18 | 0.36790384 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.83918914 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.78507115 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.47922812 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.93218086 |
| 5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.80853441 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 1.78129731 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 1.77636064 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 1.71813179 |
| 9 | Insulin secretion_Homo sapiens_hsa04911 | 1.68661103 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 1.67927999 |
| 11 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.67081696 |
| 12 | GABAergic synapse_Homo sapiens_hsa04727 | 1.63121305 |
| 13 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.61800817 |
| 14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.61752473 |
| 15 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.57019420 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.56996407 |
| 17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.56328753 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.52569562 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.51191844 |
| 20 | Salivary secretion_Homo sapiens_hsa04970 | 1.50753239 |
| 21 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.50155199 |
| 22 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.49600487 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45739198 |
| 24 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.45360699 |
| 25 | Morphine addiction_Homo sapiens_hsa05032 | 1.44422776 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.35026999 |
| 27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.33911428 |
| 28 | ABC transporters_Homo sapiens_hsa02010 | 1.33076372 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.31976975 |
| 30 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.31358161 |
| 31 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.31283908 |
| 32 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.27606746 |
| 33 | Renin secretion_Homo sapiens_hsa04924 | 1.26512168 |
| 34 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.25920690 |
| 35 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.21808636 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.18517731 |
| 37 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.14420173 |
| 38 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.12946628 |
| 39 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.12598027 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07180787 |
| 41 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.06910812 |
| 42 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.06604197 |
| 43 | Glioma_Homo sapiens_hsa05214 | 1.06257558 |
| 44 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.05596841 |
| 45 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.05438835 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.03674226 |
| 47 | Cocaine addiction_Homo sapiens_hsa05030 | 1.02715914 |
| 48 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.02704788 |
| 49 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.02390021 |
| 50 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.01002388 |
| 51 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.99715616 |
| 52 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.99099474 |
| 53 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.98247340 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.98031550 |
| 55 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.95723580 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.94295112 |
| 57 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.92927970 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.92349222 |
| 59 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92277821 |
| 60 | Insulin resistance_Homo sapiens_hsa04931 | 0.92048750 |
| 61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90489987 |
| 62 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.90419632 |
| 63 | Long-term depression_Homo sapiens_hsa04730 | 0.89496689 |
| 64 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.89266061 |
| 65 | Gap junction_Homo sapiens_hsa04540 | 0.88780165 |
| 66 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.87879847 |
| 67 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.87500153 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86952432 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86819182 |
| 70 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.86058785 |
| 71 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.85690109 |
| 72 | Taste transduction_Homo sapiens_hsa04742 | 0.85569410 |
| 73 | Lysine degradation_Homo sapiens_hsa00310 | 0.83938099 |
| 74 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.81873981 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.80274233 |
| 76 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.80000013 |
| 77 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.79403253 |
| 78 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.78519844 |
| 79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77882132 |
| 80 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.76066378 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75249109 |
| 82 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75138189 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73840292 |
| 84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72397509 |
| 85 | Melanogenesis_Homo sapiens_hsa04916 | 0.69849939 |
| 86 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.69107169 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68299492 |
| 88 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.68158035 |
| 89 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.67376403 |
| 90 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.67083997 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67034242 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65811368 |
| 93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64227497 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63299621 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62620592 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62540812 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | 0.62062381 |
| 98 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.59365272 |
| 99 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.58528370 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58180327 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56977717 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56903129 |
| 103 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56791350 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56573811 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55895410 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55689835 |
| 107 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54865431 |
| 108 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54715073 |
| 109 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.54546524 |
| 110 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54137691 |
| 111 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.53914297 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53235876 |
| 113 | Axon guidance_Homo sapiens_hsa04360 | 0.52463522 |
| 114 | Carbon metabolism_Homo sapiens_hsa01200 | 0.50676752 |
| 115 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.48228506 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47948080 |
| 117 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47414059 |
| 118 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.47018765 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46880557 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43776967 |
| 121 | Platelet activation_Homo sapiens_hsa04611 | 0.43275360 |
| 122 | Peroxisome_Homo sapiens_hsa04146 | 0.43018728 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42885143 |
| 124 | Phototransduction_Homo sapiens_hsa04744 | 0.42880672 |
| 125 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42398788 |
| 126 | Focal adhesion_Homo sapiens_hsa04510 | 0.42072881 |
| 127 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.42051816 |
| 128 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41798969 |
| 129 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.41688508 |
| 130 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41539526 |
| 131 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41506986 |
| 132 | Prion diseases_Homo sapiens_hsa05020 | 0.41362225 |
| 133 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.41334569 |
| 134 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.41305107 |
| 135 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40885929 |
| 136 | Amoebiasis_Homo sapiens_hsa05146 | 0.40194032 |
| 137 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40128127 |
| 138 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37117288 |
| 139 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35495582 |

